NYSE : AMWL
American Well Corporation — Key statistics
Healthcare · Health Information Services · United States
Last price 14.98 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 254.79M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 216.35M |
| Enterprise Value | 23.38M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 15.36M |
| Shares Outstanding | 17.01M |
| Shares Change (YoY) | +6.26% |
| Shares Change (QoQ) | +1.03% |
| Owned by Insiders (%) | 15.50% |
| Owned by Institutions (%) | 28.75% |
| Float | 11.94M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.99 |
| Forward PS | 1.06 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 1.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.90 |
| Quick Ratio | 2.72 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -29.12% |
| Return on Assets (ROA) | -12.65% |
| Return on Invested Capital (ROIC) | -16.82% |
| Return on Capital Employed (ROCE) | -30.70% |
| Weighted Average Cost of Capital (WACC) | 13.29% |
| Revenue Per Employee | $388,835 |
| Profits Per Employee | -$138,991 |
| Employee Count | 562 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 65.83 |
Taxes
| Measure | Value |
|---|
| Income Tax | 260,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +145.40% |
| 50-Day Moving Average | 12.94 |
| 200-Day Moving Average | 8.97 |
| Relative Strength Index (RSI) | 47.47 |
| Average Volume (20 Days) | 112,264 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 206,587 |
| Short Previous Month | 160,460 |
| Short % of Shares Out | 1.21% |
| Short % of Float | 1.73% |
| Short Ratio (days to cover) | 2.23 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 218.53M |
| Gross Profit | 114.91M |
| Operating Income | -72.43M |
| Pretax Income | -76.75M |
| Net Income | -78.11M |
| EBITDA | -39.89M |
| EBIT | -72.43M |
| Loss Per Share | -$4.74 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 195.95M |
| Total Debt | 2.98M |
| Net Cash | 192.97M |
| Net Cash Per Share | $11.35 |
| Equity (Book Value) | 234.31M |
| Book Value Per Share | 13.07 |
| Working Capital | 173.43M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -26.39M |
| Capital Expenditures | -25,000 |
| Depreciation & Amortization | 32.54M |
| Net Borrowing | n/a |
| Free Cash Flow | -26.41M |
| FCF Per Share | -$1.55 |
Margins
| Measure | Value |
|---|
| Gross Margin | 52.58% |
| Operating Margin | -33.15% |
| Pretax Margin | -35.12% |
| Profit Margin | -35.75% |
| EBITDA Margin | -18.26% |
| EBIT Margin | -33.15% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.26% |
| Shareholder Yield | -6.26% |
| Earnings Yield | -37.23% |
| FCF Yield | -12.20% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.80 |
| Price Target Difference | 0.63% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -3.62% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.68 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |